NovoCure Ltd — Director's Dealing 2019

Sep 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-09-13

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-13	Ordinary Shares	M	25000	$3.44	Acquired	112179	Direct
2019-09-13	Ordinary Shares	S	11098	$79.237	Disposed	101081	Direct
2019-09-13	Ordinary Shares	S	13502	$80.269	Disposed	87579	Direct
2019-09-13	Ordinary Shares	S	400	$80.959	Disposed	87179	Direct
2019-09-16	Ordinary Shares	M	25000	$3.44	Acquired	112179	Direct
2019-09-16	Ordinary Shares	S	2700	$78.325	Disposed	109479	Direct
2019-09-16	Ordinary Shares	S	22300	$79.007	Disposed	87179	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-13	Options to Buy Ordinary Shares	$3.44	M	25000	Disposed	2021-12-13	Ordinary Shares (25000)	Direct
2019-09-16	Options to Buy Ordinary Shares	$3.44	M	25000	Disposed	2021-12-13	Ordinary Shares (25000)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.

F2: On September 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 11,098 shares in multiple trades at prices ranging from $78.760 to $79.75. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On September 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 13,502 shares in multiple trades at prices ranging from $79.89 to $80.87. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On September 13, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 400 shares in multiple trades at prices ranging from $80.92 to $80.98. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: On September 16, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,700 shares in multiple trades at prices ranging from $77.54 to $78.54. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F6: On September 16, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 22,300 shares in multiple trades at prices ranging from $78.60 to $79.46. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F7: Fully vested as of the date hereof.